文献速递糖尿病

1型糖尿病供者与NOD小鼠胰腺淋巴结基质细胞的表型改变

Phenotypic alterations in pancreatic lymph node stromal cells from human donors with type 1 diabetes and NOD mice.
PubMed 文献 · Diabetologia · 2019-09-05

该研究分析了1型糖尿病供者和NOD小鼠胰腺淋巴结中淋巴结基质细胞(LNSC)的分布与表型。结果显示LNSC亚群频率改变,人类1型糖尿病中MHC II类和PD-L1表达上调,耐受相关基因在LNSC中上调而在AIRE富集树突状细胞中下调。LNSC呈现增强的致耐受表型,可能代偿树突状细胞耐受缺陷。

要点

  • 1型糖尿病中胰腺淋巴结LNSC亚群频率改变且MHC II类与PD-L1表达上调。
  • 耐受相关基因在LNSC中上调,但在AIRE富集树突状细胞中下调。
  • LNSC可能作为重新建立耐受的替代治疗靶点。

核心结论

  • LNSC在1型糖尿病中发生显著改变,呈现增强的致耐受表型及抗原提呈潜力,可能代偿树突状细胞相关耐受缺陷。

研究设计与样本

  • 研究采用流式细胞术分析1型糖尿病供者和NOD小鼠胰腺淋巴结中LNSC的分布与表型,并评估人类不同LNSC亚群及HLA-DRhigh CD45low AIRE富集树突状细胞群的耐受相关基因表达。

主要发现

  • 1型糖尿病供者和NOD小鼠中LNSC亚群相对频率均发生改变。
  • 人类1型糖尿病中LNSC的MHC II类和PD-L1表达上调。
  • 耐受相关基因在人与小鼠LNSC稳态表达谱相似,但在人类1型糖尿病中普遍上调。
  • AIRE富集树突状细胞群中许多耐受相关基因下调。

临床怎么用

  • LNSC可能作为替代治疗靶点,用于递送抗原以帮助重建耐受、预防或治疗1型糖尿病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Tolerance induction in lymph nodes can be mediated by both haematopoietic cells (e.g. specific dendritic cells subsets) and by non-haematopoietic cells (e.g. lymph node stromal cells [LNSCs]) when they present peripheral tissue antigens to autoreactive T cells. LNSCs normally regulate T cell trafficking and survival and help to maintain peripheral tolerance by exerting immunosuppressive effects. However, whether autoimmunity can be associated with defective tolerogenic functions of LNSCs is unknown and studies aimed at characterising LNSCs in humans are lacking. We hypothesised that dysregulated T cell responses in pancreatic lymph nodes (PLNs) from donors with type 1 diabetes and from NOD mice may be associated with altered LNSC function. METHODS: We analysed PLNs from donors with type 1 diabetes and NOD mice for LNSC distribution and phenotype using flow cytometry. We assessed the expression of tolerance-related genes in different subsets of LNSCs from human donors, as well as in a population of dendritic cells enriched in autoimmune regulator (AIRE)+ cells and identified as HLA-DRhigh CD45low. RESULTS: The relative frequency of different LNSC subsets was altered in both donors with type 1 diabetes and NOD mice, and both MHC class II and programmed death-ligand 1 (PD-L1) expression were upregulated in human type 1 diabetes. Tolerance-related genes showed similar expression profiles between mouse and human LNSCs at steady state but were generally upregulated in the context of human type 1 diabetes, while, at the same time, many such genes were downregulated in the AIRE-enriched dendritic cell population. CONCLUSION/INTERPRETATION: Our study shows that LNSCs are substantially altered in type 1 diabetes, but, surprisingly, they exhibit an enhanced tolerogenic phenotype along with increased antigen-presenting potential, which may indicate an attempt to offset dendritic cell-related tolerogenic defects in tolerance. Thus, LNSCs could constitute alternative therapeutic targets in which to deliver antigens to help re-establish tolerance and prevent or treat type 1 diabetes. DATA AVAILABILITY: All data generated or analysed during this study are included in the published article (and its online supplementary files). Biomark gene expression data were deposited on the Mendeley repository at https://data.mendeley.com/datasets/d9rdzdmvyf/1 . Any other raw datasets are available from the corresponding author on reasonable request. No applicable resources were generated or analysed during the current study.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Postigo-Fernandez J, Farber DL, Creusot RJ, et al. Phenotypic alterations in pancreatic lymph node stromal cells from human donors with type 1 diabetes and NOD mice. Diabetologia. 2019. PMID: 31486854. doi:10.1007/s00125-019-04984-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。